SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 100 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,124,476 | +165.9% | 52,035 | +78.7% | 0.00% | +100.0% |
| Q3 2023 | $422,822 | -48.6% | 29,120 | -25.9% | 0.00% | -66.7% |
| Q2 2023 | $822,193 | +47.1% | 39,283 | +20.6% | 0.00% | +50.0% |
| Q2 2021 | $559,000 | -6.2% | 32,575 | +22.3% | 0.00% | -33.3% |
| Q1 2021 | $596,000 | -70.6% | 26,639 | -70.8% | 0.00% | -80.0% |
| Q4 2020 | $2,027,000 | +109.6% | 91,127 | +39.2% | 0.02% | +15.4% |
| Q3 2020 | $967,000 | +221.3% | 65,484 | +222.4% | 0.01% | +160.0% |
| Q2 2020 | $301,000 | -15.2% | 20,313 | -37.2% | 0.01% | -44.4% |
| Q1 2020 | $355,000 | +327.7% | 32,356 | +73.9% | 0.01% | +800.0% |
| Q4 2018 | $83,000 | -16.2% | 18,601 | +51.3% | 0.00% | 0.0% |
| Q3 2018 | $99,000 | +11.2% | 12,298 | +20.4% | 0.00% | -50.0% |
| Q4 2017 | $89,000 | – | 10,216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $19,588,000 | 3.91% |
| Ghost Tree Capital, LLC | 575,000 | $10,988,000 | 3.21% |
| Avidity Partners Management LP | 4,823,400 | $92,175,000 | 2.04% |
| BVF INC/IL | 2,486,429 | $47,516,000 | 1.85% |
| FRAZIER MANAGEMENT LLC | 1,188,135 | $22,705,000 | 1.82% |
| Nantahala Capital Management | 2,657,159 | $50,778,000 | 1.60% |
| Boxer Capital, LLC | 2,287,782 | $43,720,000 | 1.53% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,939,000 | 1.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 750,603 | $14,344,000 | 1.20% |
| PFM Health Sciences, LP | 1,856,738 | $35,482,000 | 1.04% |